| Tap a line for its trend | Currentlast close | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 |
|---|
| 753 | — | — | — | |
| 2.8 | 2.8 | 0.6 | 0.1 | |
| 100 | 100 | 85.5 | 77.1 | |
| 850 | — | — | — | |
| 366 | 366 | 283 | 245 | |
| — | +29.1% | +15.8% | — | |
| 33.8 | 33.8 | 40.4 | 31.2 | |
| 9.2% | 9.2% | 14.3% | 12.7% | |
| 24.0 | 24.0 | 33.1 | 24.7 | |
| 14.6 | 14.6 | 18.8 | 13.7 | |
| 4.0% | 4.0% | 6.7% | 5.6% | |
| ₹19.83 | ₹19.83 | ₹25.63 | ₹18.57 | |
| — | −22.6% | +38.0% | — | |
| 48.0 | 48.0 | 42.1 | 14.1 | |
| −49.8 | −49.8 | −41.4 | −8.2 | |
| −1.9 | −1.9 | 0.6 | 5.9 | |
From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.
In ₹ Crore except Per Share 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | Current last close | |
|---|---|---|---|---|---|
| Market Capitalization | — | — | — | 752.7 | |
| - Cash, Equiv & ST Investments | 0.1 | 0.6 | 2.8 | 2.8 | |
| + Total Debt | 77.1 | 85.5 | 100.4 | 100.4 | |
| Enterprise Value | — | — | — | 850.3 | |
| Revenue | 244.8 | 283.4 | 365.8 | 365.8 | |
| Growth %, YoY | — | +15.8 | +29.1 | — | |
| EBITDA | 31.2 | 40.4 | 33.8 | 33.8 | |
| Margin % | 12.73 | 14.27 | 9.23 | 9.23 | |
| EBIT | 24.7 | 33.1 | 24.0 | 24.0 | |
| Net Income | 13.7 | 18.8 | 14.6 | 14.6 | |
| Margin % | 5.58 | 6.65 | 3.99 | 3.99 | |
| EPS, Adj (current shares) | 18.57 | 25.63 | 19.83 | 19.83 | |
| Growth %, YoY | — | +38.0 | -22.6 | — | |
| Cash from Operations | 14.1 | 42.1 | 48.0 | 48.0 | |
| Capital Expenditures | -8.2 | -41.4 | -49.8 | -49.8 | |
| Free Cash Flow | 5.9 | 0.6 | -1.9 | -1.9 | |
Figures from the company's filings with NSE
In FY25 its consolidated net profit was ₹14.6 crore on revenue of ₹366 crore. Its debt-to-equity ratio was 1.05 on 31 March 2025.
No. Sunshield Chemicals had borrowings of ₹100 crore on 31 March 2025 (consolidated balance sheet), a debt-to-equity ratio of 1.05. Its cash and current investments were ₹3.7 crore, so its net debt was ₹96.7 crore.
Sunshield Chemicals' debt-to-equity ratio was 1.05 on 31 March 2025: borrowings of ₹100 crore against total equity of ₹95.7 crore.
Sunshield Chemicals' book value per share was ₹130.11 on 31 March 2025: shareholders' equity of ₹95.7 crore divided by the 73.55 lakh shares in issue.
Sunshield Chemicals' net worth — shareholders' equity in its consolidated balance sheet — was ₹95.7 crore on 31 March 2025.
Sunshield Chemicals' basic earnings per share (EPS) were ₹19.83 in FY25, against ₹25.63 in FY24.
In 2026, Sunshield Chemicals has declared one dividend: ₹3 (final) with record date 11 June 2026.
In FY25, Sunshield Chemicals' return on equity (ROE) was 16.4% and its return on capital employed (ROCE) was 20.4%. ROE is net profit divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities). In FY24, ROE was 25.4% and ROCE 29.6%.
In FY25, Sunshield Chemicals generated ₹48 crore of cash from operations and spent ₹49.8 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of −₹1.9 crore. In FY24 it was ₹62 lakh.
In FY25 (April 2024–March 2025), Sunshield Chemicals' consolidated net profit was ₹14.6 crore, down 22.6% from ₹18.8 crore in FY24, on revenue from operations of ₹366 crore (up 29.1%). Over three years, from FY21, net profit was up 2.8%.
On FY25 consolidated figures, against ARCL Organics: Sunshield Chemicals' operating margin of 6.6% is the lower of the two (ARCL Organics 7.4%; peer average 7.4%); its return on equity of 16.4% is the higher of the two (ARCL Organics 15.5%; peer average 15.5%).
In FY25, Sunshield Chemicals earned net profit of ₹14.6 crore on revenue of ₹366 crore, against ₹11.8 crore on ₹251 crore for ARCL Organics. Sunshield Chemicals' operating margin was 6.6% (ARCL Organics 7.4%) and its return on equity 16.4% (ARCL Organics 15.5%).
From Sunshield Chemicals' own consolidated results, balance sheets and shareholding patterns filed with NSE. Ratios are calculated by Alphave from those filings as each answer describes.
Consolidated figures from the company's filings with NSE; prices are NSE closing prices.